InvestorsHub Logo
Followers 17
Posts 1224
Boards Moderated 1
Alias Born 06/30/2014

Re: None

Sunday, 10/04/2020 2:37:17 PM

Sunday, October 04, 2020 2:37:17 PM

Post# of 140474
Reply 117063 Geo, so you would sell it before FDA for less? Why? There would most likely be a very attractive version being demonstrated by MDT, with ours in the wings. Surely you would pay off the loan and orchestrate an auction with a high reserve - right?

This "sell it for less and get out early" theory does not fit anywhere I look, so long as there's a big competitor that doesn't have a SP robot. Mc doesn't work for MDT - yet. He works for us, and now whomever holds that $18M offering.

You think Wall Street is going to say "ok Medtronic, you can have SP RAS for a song for the next 20 years?" Not likely. Worse case is ISRG goes on an over-the-counter buying spree and really hurts MDT.
That would trigger an early move to BO, IMO. But it would still be at a robust price. Wall Street has deep pockets, and will buy as long as MDT dickers with TMDI about price, and the share price keeps going up the longer they thumb-wrestle.

MDT has as much downside exposure as we do. MDT has to make sure if there is any other public offerings that it's friendly. MDT does care as to who holds any outstanding shares. They care to not create a 20 year headache, if any of this gets in the hands of a BIG competitor. Which is why I agree with Roll/66 or whomever said it first that MDT issues more IP licensing payments, to get to the finish.

Regards,BK.